NASDAQ:SLXN | Cash Flow Statement | Silexion Therapeutics Corp

Complete source-backed cash-flow history.

Available history
2023-06-30 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$3.55M-$2.93M$0.00-$1,000.00$2.74M
2026-03-31-$2.73M-$3.65M$0.00$0.00$83,000.00
2025-12-31-$4.41M-$3.02M$2,000.00-$7,000.00-$221,000.00
2025-09-30-$3.26M-$2.84M$0.00$0.00$8.62M
2025-06-30-$2.5M-$2.51M$1,000.00-$1,000.00-$195,000.00
2025-03-31-$1.74M-$2.45M$6,000.00-$6,000.00$7.43M
2024-12-31-$1.75M-$2.93M$0.00$0.00$2.18M
2024-09-30-$11.86M-$2.65M$16,000.00-$16,000.00$2.92M
2024-06-30-$1.49M-$1.07M$0.00$0.00$0.00
2024-03-31-$1.42M-$1.75M$6,000.00-$6,000.00
2023-12-31-$1.68M-$1.26M$4,000.00-$4,000.00$0.00
2023-09-30-$809,000.00-$685,000.00$6,000.00$72,000.00$0.00
2023-06-30-$1.88M-$1.68M$2,000.00-$2,000.00$522,000.00

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$11.91M-$10.82M$9,000.00-$14,000.00$15.64M
2024-12-31-$16.52M-$8.4M$22,000.00-$22,000.00$5.1M
2023-12-31-$5.11M-$4.53M$12,000.00$573,000.00$522,000.00

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.